Literature DB >> 526405

Use of labetalol during halothane anaesthesia.

D H Cope.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 526405      PMCID: PMC1429762     

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  9 in total

1.  The action of fluothane; a new volatile anaesthetic.

Authors:  J RAVENTOS
Journal:  Br J Pharmacol Chemother       Date:  1956-12

2.  Haemodynamic effects of sodium nitroprusside during nitrous oxide-halothane anaesthesia.

Authors:  J A Wildsmith; R L Marshall; J L Jenkinson; W R MacRae; D B Scott
Journal:  Br J Anaesth       Date:  1973-01       Impact factor: 9.166

3.  Sodium nitroprusside as a hypotensive agent in general anaesthesia.

Authors:  T H Taylor; M Styles; A J Lamming
Journal:  Br J Anaesth       Date:  1970-10       Impact factor: 9.166

4.  Severe metabolic acidosis following hypotension induced with sodium nitroprusside. Case report.

Authors:  W R MacRae; M Owen
Journal:  Br J Anaesth       Date:  1974-10       Impact factor: 9.166

5.  Toxicity of sodium nitroprusside.

Authors:  R D Jack
Journal:  Br J Anaesth       Date:  1974-12       Impact factor: 9.166

6.  Propranolol during controlled hypotension.

Authors:  J Hellewell; M W Potts
Journal:  Br J Anaesth       Date:  1966-10       Impact factor: 9.166

7.  Cardiovascular effects of labetalol during halothane anaesthesia.

Authors:  D B Scott; F P Buckley; G B Drummond; D G Littlewoods; W R Macrae
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

8.  Labetalol in controlled hypotension: administration of labetalol when adequate hypotension is difficult to achieve.

Authors:  D H Cope; M C Crawford
Journal:  Br J Anaesth       Date:  1979-04       Impact factor: 9.166

9.  Circulatory effects of labetalol during halothane anaesthesia.

Authors:  D B Scott; F P Buckley; D G Littlewood; W R Macrae; G R Arthur; G B Drummond
Journal:  Anaesthesia       Date:  1978-02       Impact factor: 6.955

  9 in total
  2 in total

1.  Labetalol, an alpha- and beta-adrenoceptor-blocking agent: its use in therapeutics. A summary of the symposium.

Authors:  B N Prichard; D A Richards
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

Review 2.  Combined alpha- and beta-receptor inhibition in the treatment of hypertension.

Authors:  B N Prichard
Journal:  Drugs       Date:  1984       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.